MitrAssist's "valve-in-valve" approach overcomes the challenges of MR and offers an improved treatment solution for all MR patients. The company's innovative cardiac implant is designed to enhance valve functionality and has significant advantages over existing and in-development minimally invasive solutions. MitrAssist is a leading angiocarpy treatment devices platform with a globally recognized reputation for its cutting-edge innovation.